Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-cash Items (2018 - 2025)

Bicycle Therapeutics' Non-cash Items history spans 8 years, with the latest figure at $6.6 million for Q4 2025.

  • For Q4 2025, Non-cash Items fell 30.53% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $6.6 million, down 30.53%, while the annual FY2025 figure was $6.6 million, 23.92% up from the prior year.
  • Non-cash Items reached $6.6 million in Q4 2025 per BCYC's latest filing, roughly flat from $6.6 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $207.0 million in Q4 2021 to a low of $2.0 million in Q1 2021.
  • Average Non-cash Items over 5 years is $25.6 million, with a median of $6.3 million recorded in 2025.
  • Peak YoY movement for Non-cash Items: tumbled 93.46% in 2021, then soared 1900.1% in 2022.
  • A 5-year view of Non-cash Items shows it stood at $207.0 million in 2021, then tumbled by 65.7% to $71.0 million in 2022, then plummeted by 69.13% to $21.9 million in 2023, then crashed by 56.39% to $9.6 million in 2024, then crashed by 30.53% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for BCYC's Non-cash Items are $6.6 million (Q4 2025), $6.6 million (Q3 2025), and $2.7 million (Q2 2025).